U.S. Markets closed
  • S&P 500

    4,246.59
    -8.56 (-0.20%)
     
  • Dow 30

    34,299.33
    -94.42 (-0.27%)
     
  • Nasdaq

    14,072.86
    -101.29 (-0.71%)
     
  • Russell 2000

    2,320.07
    -6.07 (-0.26%)
     
  • Crude Oil

    72.47
    +0.35 (+0.49%)
     
  • Gold

    1,859.40
    +3.00 (+0.16%)
     
  • Silver

    27.81
    +0.12 (+0.42%)
     
  • EUR/USD

    1.2129
    -0.0004 (-0.0364%)
     
  • 10-Yr Bond

    1.4990
    -0.0020 (-0.13%)
     
  • Vix

    17.02
    +0.63 (+3.84%)
     
  • GBP/USD

    1.4082
    -0.0001 (-0.0042%)
     
  • USD/JPY

    110.0850
    +0.0510 (+0.0464%)
     
  • BTC-USD

    40,345.34
    -139.10 (-0.34%)
     
  • CMC Crypto 200

    995.03
    -15.57 (-1.54%)
     
  • FTSE 100

    7,172.48
    +25.80 (+0.36%)
     
  • Nikkei 225

    29,441.30
    +279.50 (+0.96%)
     

Moderna's new supply deal with Australia is for 25 million COVID-19 vaccine doses

·1 min read
Moderna's new supply deal with Australia is for 25 million COVID-19 vaccine doses
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Moderna Inc. announced Wednesday a new agreement to supply 25 million doses of its COVID-19 vaccine to Australia. The agreement includes 10 million doses of the biotechnology company's mRNA-1273 vaccine to be delivered this year and 15 million doses of its variant booster vaccine candidate to be delivered in 2022. The agreement is subject to approval of mRNA-1273 and the booster vaccine candidate by Australia's Therapeutic Goods Administration. Moderna's stock, which fell 0.2% in premarket trading, has run up 52.2% year to date through Tuesday, while the S&P 500 has gained 10.5%.